Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Amryt Pharma

Biotech & Life Sciences · Dublin, Ireland · Founded 2004 · IPO 2012 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.25B
Market cap · 2026
Revenue
$223M
Latest reported FY

Investors

6 investors on Amryt Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 6 investors entered at this stage
ARCH Venture Partners
7 Health Ventures
MPM BioImpact
F2 Ventures
XT Investments
Abingworth

Global footprint

Where Amryt Pharma has talent and traffic

Web traffic by country
290 monthly visits
across markets
🇮🇳 India103.4%
Top 1 markets shown

Patent intelligence

$184M patent portfolio · 53 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$184M
14.7% of market cap · 2.4× smaller than top peer Alexion Pharmaceuticals ($444M)
53 active patent families
Where Amryt Pharma innovates DiseaseCombination therapyMolecular biologyOral administrationAcromegaly
Above peer median on Market

Quality vs same-sector peers

Amryt Pharma on the five Patsnap quality dimensions

Amryt Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Amryt Pharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Amryt Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Amryt Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo